Management of Retropharyngeal Lymph Node Metastases in Differentiated Thyroid Carcinoma.

BACKGROUND Retropharyngeal lymph node metastases (RPMs) from differentiated thyroid carcinoma (DTC) are rare. Treatment includes surgical resection, radioactive iodine (RAI) therapy, or external beam radiotherapy (EBRT). The objective of this study was to describe our experience in the management of DTC-associated RPMs. METHODS Patients diagnosed with a DTC-associated RPM from 1999 to 2018 were identified at our institution, using key search terms in imaging and histology reports. Patient and tumor characteristics were recorded, and patients were grouped according to RPM management: observation, nonsurgical treatment, or surgical resection. The estimated rates of local RPM control, disease-specific survival (DSS), and distant recurrence-free survival (DRFS) were calculated using the Kaplan-Meier method. RESULTS Of the 65 patients identified, 53 (82%) had RPM as a manifestation of recurrent disease. Twenty-five patients (38%) underwent observation, 13 (20%) received nonsurgical treatment (RAI, EBRT, and/or systemic therapy), and 27 (42%) underwent surgical resection. In the observation cohort, all patients had a stable RPM, which in the majority (80%) of cases remained <1.5 cm during the period of observation (median 28 months). Of the 13 patients in the nonsurgical treatment cohort, 3 received RAI therapy, 7 received EBRT, and 3 received systemic therapy only. In the surgical cohort, the median RPM maximum diameter was 2.0 cm (range 0.8-4.2 cm). The size of the RPM was predictive of surgical resection versus observation (p <0.001). A transcervical approach was employed in 19 patients, and a transoral approach in 8. The 5-year rate of local RPM control was 92%. For the whole cohort, the 5- and 10-year DRFS were 72% and 62%, respectively; the 5- and 10-year DSS were 93% and 81%, respectively. CONCLUSIONS DTC-associated RPM manifests as recurrent disease in the majority of patients. Select patients with a small-volume and nonprogressive RPM may be suitable for observation whereas surgery is likely warranted in large or progressing RPMs. In general, the presence of a RPM from DTC appears to be associated with aggressive disease.

[1]  B. Fornage,et al.  Transoral resection of thyroid cancer metastasis to lateral retropharyngeal nodes , 2007, Head & neck.

[2]  S. Moritani Parapharyngeal Metastasis of Papillary Thyroid Carcinoma , 2016, World Journal of Surgery.

[3]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[4]  G. Randolph,et al.  Mapping the distribution of nodal metastases in papillary thyroid carcinoma: Where exactly are the nodes? , 2017, The Laryngoscope.

[5]  VALERIE A. SMITH,et al.  Cervical lymph node metastasis and papillary thyroid carcinoma: Does the compartment involved affect survival? Experience from the SEER database , 2012, Journal of surgical oncology.

[6]  Michelle D. Williams,et al.  Retropharyngeal lymphadenectomy with transoral robotic surgery for papillary thyroid cancer , 2011, Journal of robotic surgery.

[7]  A. Hayen,et al.  A preoperative nomogram for the prediction of ipsilateral central compartment lymph node metastases in papillary thyroid cancer. , 2014, Thyroid : official journal of the American Thyroid Association.

[8]  S. Iwae,et al.  Retropharyngeal node metastasis from papillary thyroid carcinoma , 2007, Head & neck.

[9]  B. Edeiken,et al.  Technical refinement of ultrasound‐guided transoral resection of parapharyngeal/retropharyngeal thyroid carcinoma metastases , 2011, Head & neck.

[10]  V. Zaydfudim,et al.  The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. , 2008, Surgery.

[11]  A. Shaha,et al.  Parapharyngeal lymph node metastasis: An unusual presentation of papillary thyroid carcinoma , 2004, Head & neck.

[12]  V. Grégoire,et al.  Parapharyngeal metastases from thyroid cancer. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[13]  J. Jimeno,et al.  Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. , 2005, Surgery.

[14]  V. Chong,et al.  Radiology of the retropharyngeal space. , 2000, Clinical radiology.

[15]  M. Schlumberger,et al.  Management of Retropharyngeal Node Metastases from Thyroid Carcinoma , 2015, World Journal of Surgery.

[16]  N. Gross,et al.  Transoral robotic retropharyngeal node dissection , 2016, Head & neck.

[17]  Quan-Yong Luo,et al.  Localization and identification of parapharyngeal metastases from differentiated thyroid carcinoma by 131I‐SPECT/CT , 2011, Head & neck.

[18]  A J BALLANTYNE,et al.  SIGNIFICANCE OF RETROPHARYNGEAL NODES IN CANCER OF THE HEAD AND NECK. , 1964, American journal of surgery.

[19]  I. Sugitani,et al.  Surgical Management of Retropharyngeal Nodes Metastases from Papillary Thyroid Carcinoma , 2014, World Journal of Surgery.